DMIIU Drugs Made In America Acquisition II Corp. - Unit
$10.15
Price · May 19, 2026
Fundamentals as of Apr 15, 2026
52W Range
$10–$11
25% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-46.6%
Net Profit Margin
—
DMIIU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.15
Market Cap
$137M
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-46.6%
Debt/Equity
—
52W Range
$10 – $11
DMIIU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DMIIU
Peer Median
P/B
-7.7
1.0
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DMIIU
Peer Median
ROA
1.7%
2.0%
ROE
-46.6%
2.0%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DMIIU
Peer Median
Current Ratio
0.1
0.5
Quick Ratio
0.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DMIIU
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DMIIU
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 7
| Metric | Trend | 2025 |
|---|---|---|
| SG&A Expense | $488.4K | |
| Operating Expenses | $488.4K | |
| Operating Income | $-488.4K | |
| Interest Income | $5M | |
| Other Non-op | $5M | |
| Net Income | $4M | |
| EBITDA | $-488.4K |
Balance Sheet 13
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $223 | |
| Prepaid Expense | $25.8K | |
| Current Assets | $26.0K | |
| Total Assets | $505M | |
| Accounts Payable | $99.4K | |
| Accrued Liabilities | $88.3K | |
| Current Liabilities | $300.9K | |
| Total Liabilities | $18M | |
| Common Stock | $1.4K | |
| Retained Earnings | $-18M | |
| Stockholders' Equity | $-18M | |
| Liabilities + Equity | $505M | |
| Shares Outstanding | 13,700,000 |
Cash Flow 3
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-1M | |
| Investing Cash Flow | $-500M | |
| Financing Cash Flow | $501M |
Profitability 2
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 1.7% | |
| ROE | -46.6% |
Liquidity & Solvency 2
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 0.1 | |
| Quick Ratio | 0.0 |
Valuation (TTM) 4
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $4M | |
| Market Cap | $137M | |
| P/B | -7.7 | |
| P / Cash Flow | -134.7 |
Income Statement 6
| Metric | Trend | Q4 2025 | Q3 2025 |
|---|---|---|---|
| SG&A Expense | $235.5K | $155.5K | |
| Operating Income | $-235.5K | $-155.5K | |
| Interest Income | $5M | $109.4K | |
| Other Non-op | $5M | $109.4K | |
| Net Income | $4M | $-46.2K | |
| EBITDA | · | $-155.5K |
Balance Sheet 13
| Metric | Trend | Q4 2025 | Q3 2025 |
|---|---|---|---|
| Cash & Equivalents | $223 | $315.1K | |
| Prepaid Expense | $25.8K | $15.0K | |
| Current Assets | $26.0K | $896.4K | |
| Total Assets | $505M | $501M | |
| Accounts Payable | $99.4K | $4.6K | |
| Accrued Liabilities | $88.3K | $5.8K | |
| Current Liabilities | $300.9K | $677.3K | |
| Total Liabilities | $18M | $18M | |
| Common Stock | $1.4K | $1.6K | |
| Retained Earnings | $-18M | $-17M | |
| Stockholders' Equity | $-18M | $-17M | |
| Liabilities + Equity | $505M | $501M | |
| Shares Outstanding | 13,700,000 | 15,575,000 |
Cash Flow 3
| Metric | Trend | Q4 2025 | Q3 2025 |
|---|---|---|---|
| Operating Cash Flow | $-314.9K | · | |
| Investing Cash Flow | $0 | · | |
| Financing Cash Flow | $0 | · |
Profitability 2
| Metric | Trend | Q4 2025 | Q3 2025 |
|---|---|---|---|
| ROA | · | -0.02% | |
| ROE | · | 0.53% |
Liquidity & Solvency 2
| Metric | Trend | Q4 2025 | Q3 2025 |
|---|---|---|---|
| Current Ratio | · | 1.3 | |
| Quick Ratio | · | 0.5 |
Valuation (TTM) 2
| Metric | Trend | Q4 2025 | Q3 2025 |
|---|---|---|---|
| Market Cap | · | $155M | |
| P/B | · | -9.0 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $4M | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 0.1 | — |
| Quick Ratio | 0.0 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.